Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2009, Article ID 476897, 5 pages
http://dx.doi.org/10.1155/2009/476897
Clinical Study

Oral Contraceptives after Myomectomy: A Short Term Trial

Obstetrics and Gynecology Unit, Department of Pediatrics, Gynecology, and Reproductive Medicine, University of Siena, 53100 Siena, Italy

Received 5 February 2009; Revised 4 May 2009; Accepted 4 June 2009

Academic Editor: Anil K. Agarwal

Copyright © 2009 Stefano Luisi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Marshall, D. Spiegelman, M. B. Goldman et al., “A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata,” Fertility and Sterility, vol. 70, no. 3, pp. 432–439, 1998. View at Publisher · View at Google Scholar
  2. R. K. Ross, M. C. Pike, M. P. Vessey, D. Bull, D. Yeates, and J. T. Casagrande, “Risk factors for uterine fibroids: reduced risk associated with oral contraceptives,” British Medical Journal, vol. 293, no. 6543, pp. 359–362, 1986. View at Google Scholar
  3. F. Parazzini, C. La Vecchia, E. Negri, G. Cecchetti, and L. Fedele, “Epidemiologic characteristics of women with uterine fibroids: a case-control study,” Obstetrics and Gynecology, vol. 72, no. 6, pp. 853–857, 1988. View at Google Scholar
  4. L. M. Marshall, D. Spiegelman, R. L. Barbieri et al., “Variation in the incidence of uterine leiomyoma among premenopausal women by age and race,” Obstetrics and Gynecology, vol. 90, no. 6, pp. 967–973, 1997. View at Publisher · View at Google Scholar
  5. I. Romieu, A. M. Walker, and S. Jick, “Determinants of uterine fibroids,” Post Marketing Surveillance, vol. 5, no. 2, pp. 119–133, 1991. View at Google Scholar
  6. R. K. Yantiss, P. B. Clement, and R. H. Young, “Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases,” American Journal of Surgical Pathology, vol. 24, no. 4, pp. 513–524, 2000. View at Publisher · View at Google Scholar
  7. M. A. Lumsden and E. M. Wallace, “Clinical presentation of uterine fibroids,” Bailliere's Clinical Obstetrics and Gynaecology, vol. 12, no. 2, pp. 177–195, 1998. View at Publisher · View at Google Scholar
  8. J. Andersen and R. L. Barbieri, “Abnormal gene expression in uterine leiomyomas,” Journal of the Society for Gynecologic Investigation, vol. 2, no. 5, pp. 663–672, 1995. View at Publisher · View at Google Scholar
  9. A. H. John and R. Martin, “Growth of leiomyomata with estrogen—progestogen therapy,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 6, no. 2, pp. 56–58, 1971. View at Google Scholar
  10. F. Parazzini, E. Negri, C. La Vecchia, L. Fedele, M. Rabaiotti, and L. Luchini, “Oral contraceptive use and risk of uterine fibroids,” Obstetrics and Gynecology, vol. 79, no. 3, pp. 430–433, 1992. View at Google Scholar
  11. H. Ratner, “Risk factors for uterine fibroids: reduced risk associated with oral contraceptives,” British Medical Journal, vol. 293, p. 1027, 1986. View at Google Scholar
  12. A. J. Friedman and P. P. Thomas, “Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?” Obstetrics and Gynecology, vol. 85, no. 4, pp. 631–635, 1995. View at Publisher · View at Google Scholar
  13. A. A. Murphy, A. J. Morales, L. M. Kettel, and S. S. C. Yen, “Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect,” Fertility and Sterility, vol. 64, no. 1, pp. 187–190, 1995. View at Google Scholar
  14. C. M. Farquhar and C. A. Steiner, “Hysterectomy rates in the United States 1990–1997,” Obstetrics and Gynecology, vol. 99, no. 2, pp. 229–234, 2002. View at Publisher · View at Google Scholar
  15. N. S. Banu and I. T. Manyonda, “Alternative medical and surgical options to hysterectomy,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 19, no. 3, pp. 431–449, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. G. Connolly, M. Doyle, T. Barrett, P. Byrne, M. De Mello, and R. F. Harrison, “Fertility after abdominal myomectomy,” Journal of Obstetrics and Gynaecology, vol. 20, no. 4, pp. 418–420, 2000. View at Google Scholar
  17. D. W. Stovall, S. B. Parrish, B. J. Van Voorhis, S. J. Hahn, A. E. T. Sparks, and C. H. Syrop, “Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study,” Human Reproduction, vol. 13, no. 1, pp. 192–197, 1998. View at Publisher · View at Google Scholar
  18. C. Chapron and J.-B. Dubuisson, “Laparoscopic treatment of deep endometriosis located on the uterosacral ligaments,” Human Reproduction, vol. 11, no. 4, pp. 868–873, 1996. View at Google Scholar
  19. B. S. Apgar, A. H. Kaufman, U. George-Nwogu, and A. Kittendorf, “Treatment of menorrhagia,” American Family Physician, vol. 75, no. 12, pp. 1813–1819, 2007. View at Google Scholar
  20. C. Larroy, “Comparing visual-analog and numeric scales for assessing menstrual pain,” Behavioral Medicine, vol. 27, no. 4, pp. 179–181, 2002. View at Google Scholar
  21. M. Lieng, O. Istre, and A. Langebrekke, “Uterine rupture after laparoscopic myomectomy,” Journal of the American Association of Gynecologic Laparoscopists, vol. 11, no. 1, pp. 92–93, 2004. View at Publisher · View at Google Scholar
  22. A. R. Davis, C. Westhoff, K. O'Connell, and N. Gallagher, “Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial,” Obstetrics and Gynecology, vol. 106, no. 1, pp. 97–104, 2005. View at Google Scholar
  23. L. M. Marshall, D. Spiegelman, M. B. Goldman et al., “A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata,” Fertility and Sterility, vol. 70, no. 3, pp. 432–439, 1998. View at Publisher · View at Google Scholar
  24. R. L. Barbieri, “Reduction in the size of a uterine leiomyoma following discontinuation of an estrogen-progestin contraceptive,” Gynecologic and Obstetric Investigation, vol. 43, no. 4, pp. 276–277, 1997. View at Google Scholar
  25. A. J. Friedman and P. P. Thomas, “Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?” Obstetrics and Gynecology, vol. 85, no. 4, pp. 631–635, 1995. View at Publisher · View at Google Scholar
  26. G. Larsson, I. Milsom, G. Lindstedt, and G. Rybo, “The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status,” Contraception, vol. 46, no. 4, pp. 327–334, 1992. View at Publisher · View at Google Scholar